{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,6]],"date-time":"2026-02-06T08:32:13Z","timestamp":1770366733631,"version":"3.49.0"},"reference-count":53,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"name":"Sichuan Provincial Department of Science and Technology Foundation","award":["2023YFS0212"],"award-info":[{"award-number":["2023YFS0212"]}]},{"DOI":"10.13039\/501100018542","name":"Natural Science Foundation of Sichuan Province","doi-asserted-by":"crossref","award":["2022NSFSC0677"],"award-info":[{"award-number":["2022NSFSC0677"]}],"id":[{"id":"10.13039\/501100018542","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Neurobiol"],"published-print":{"date-parts":[[2026,1]]},"DOI":"10.1007\/s12035-026-05714-1","type":"journal-article","created":{"date-parts":[[2026,2,5]],"date-time":"2026-02-05T17:34:00Z","timestamp":1770312840000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Trends and Research Frontiers in Mammalian Target of Rapamycin and Alzheimer\u2019s Disease"],"prefix":"10.1007","volume":"63","author":[{"given":"Ziyan","family":"Ma","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhiqiang","family":"Xiao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zuli","family":"Yang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bin","family":"Huang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiaoping","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2026,2,5]]},"reference":[{"key":"5714_CR1","doi-asserted-by":"publisher","first-page":"1577","DOI":"10.1016\/S0140-6736(20)32205-4","volume":"397","author":"P Scheltens","year":"2021","unstructured":"Scheltens P, De Strooper B, Kivipelto M, Holstege H, Ch\u00e9telat G, Teunissen CE et al (2021) Alzheimer\u2019s disease. Lancet 397:1577\u20131590","journal-title":"Lancet"},{"key":"5714_CR2","doi-asserted-by":"crossref","unstructured":"(2021) Alzheimer's disease facts and figures. Alzheimers Dement 17:327-406","DOI":"10.1002\/alz.12328"},{"key":"5714_CR3","doi-asserted-by":"publisher","DOI":"10.3390\/ijms24010107","author":"AA Rostagno","year":"2022","unstructured":"Rostagno AA (2022) Pathogenesis of Alzheimer\u2019s disease. Int J Mol Sci. https:\/\/doi.org\/10.3390\/ijms24010107","journal-title":"Int J Mol Sci"},{"key":"5714_CR4","doi-asserted-by":"publisher","DOI":"10.3390\/ijms24076518","author":"B Twarowski","year":"2023","unstructured":"Twarowski B, Herbet M (2023) Inflammatory processes in Alzheimer\u2019s disease\u2014pathomechanism, diagnosis and treatment: a review. Int J Mol Sci. https:\/\/doi.org\/10.3390\/ijms24076518","journal-title":"Int J Mol Sci"},{"key":"5714_CR5","doi-asserted-by":"publisher","DOI":"10.1186\/s13024-021-00428-5","author":"H Querfurth","year":"2021","unstructured":"Querfurth H, Lee H-K (2021) Mammalian\/mechanistic target of rapamycin (mTOR) complexes in neurodegeneration. Mol Neurodegener. https:\/\/doi.org\/10.1186\/s13024-021-00428-5","journal-title":"Mol Neurodegener"},{"key":"5714_CR6","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2024.1366061","volume":"15","author":"PL Xie","year":"2024","unstructured":"Xie PL, Zheng MY, Han R, Chen WX, Mao JH (2024) Pharmacological mTOR inhibitors in ameliorating Alzheimer\u2019s disease: current review and perspectives. Front Pharmacol 15:1366061","journal-title":"Front Pharmacol"},{"key":"5714_CR7","doi-asserted-by":"publisher","first-page":"382","DOI":"10.1016\/j.freeradbiomed.2021.04.025","volume":"169","author":"M Perluigi","year":"2021","unstructured":"Perluigi M, Di Domenico F, Barone E, Butterfield DA (2021) mTOR in Alzheimer disease and its earlier stages: links to oxidative damage in the progression of this dementing disorder. Free Radic Biol Med 169:382\u2013396","journal-title":"Free Radic Biol Med"},{"key":"5714_CR8","doi-asserted-by":"publisher","DOI":"10.1038\/s43856-025-00904-9","volume":"5","author":"MM Gonzales","year":"2025","unstructured":"Gonzales MM, Garbarino VR, Kautz TF, Song X, Lopez-Cruzan M, Linehan L et al (2025) Rapamycin treatment for Alzheimer\u2019s disease and related dementias: a pilot phase 1 clinical trial. Commun Med 5:189","journal-title":"Commun Med"},{"key":"5714_CR9","doi-asserted-by":"publisher","DOI":"10.1097\/md.0000000000036545","author":"Y Zhang","year":"2023","unstructured":"Zhang Y, Chen M, Liu C, He B, Dang H, Li J et al (2023) Global trends and research hotspots of stroke and magnetic resonance imaging: a bibliometric analysis. Medicine (Baltimore). https:\/\/doi.org\/10.1097\/md.0000000000036545","journal-title":"Medicine (Baltimore)"},{"key":"5714_CR10","doi-asserted-by":"publisher","DOI":"10.3389\/fnint.2022.940265","author":"L Li","year":"2022","unstructured":"Li L, Xia X, Luo Y, Zhu Y, Luo X, Yang B et al (2022) Prospects and hot spots for mammalian target of rapamycin in the field of neuroscience from 2002 to 2021. Front Integr Neurosci. https:\/\/doi.org\/10.3389\/fnint.2022.940265","journal-title":"Front Integr Neurosci"},{"key":"5714_CR11","doi-asserted-by":"publisher","DOI":"10.1186\/s40001-023-01220-5","author":"S Tao","year":"2023","unstructured":"Tao S, Tang X, Yu L, Li L, Zhang G, Zhang L et al (2023) Prognosis of coronary heart disease after percutaneous coronary intervention: a bibliometric analysis over the period 2004\u20132022. Eur J Med Res. https:\/\/doi.org\/10.1186\/s40001-023-01220-5","journal-title":"Eur J Med Res"},{"key":"5714_CR12","doi-asserted-by":"publisher","first-page":"98","DOI":"10.2174\/1570159X22666240730154834","volume":"23","author":"S Li","year":"2024","unstructured":"Li S, Zhang Q, Liu J, Zhang N, Li X, Liu Y et al (2024) Bibliometric analysis of Alzheimer\u2019s disease and depression. Curr Neuropharmacol 23:98\u2013115","journal-title":"Curr Neuropharmacol"},{"key":"5714_CR13","doi-asserted-by":"publisher","DOI":"10.3389\/fnagi.2024.1423139","volume":"16","author":"W Sun","year":"2024","unstructured":"Sun W, Gong J, Li S, Wang P, Han X, Xu C et al (2024) Bibliometric analysis of neuroinflammation and Alzheimer\u2019s disease. Front Aging Neurosci 16:1423139","journal-title":"Front Aging Neurosci"},{"key":"5714_CR14","doi-asserted-by":"publisher","first-page":"5339","DOI":"10.3748\/wjg.v29.i37.5339","volume":"29","author":"J-J Dai","year":"2023","unstructured":"Dai J-J, Zhang Y-F, Zhang Z-H (2023) Global trends and hotspots of treatment for nonalcoholic fatty liver disease: a bibliometric and visualization analysis (2010-2023). World J Gastroenterol 29:5339\u20135360","journal-title":"World J Gastroenterol"},{"key":"5714_CR15","doi-asserted-by":"publisher","first-page":"631","DOI":"10.21037\/apm-21-3976","volume":"11","author":"P Qiu","year":"2022","unstructured":"Qiu P, Lin X, Li A, Deng G (2022) Research status and hotspots of cesarean scar pregnancy from 2001 to 2020: a bibliometric analysis. Ann Palliat Med 11:631\u2013646","journal-title":"Ann Palliat Med"},{"key":"5714_CR16","doi-asserted-by":"publisher","DOI":"10.3390\/bs13010019","author":"C Jia","year":"2022","unstructured":"Jia C, Mustafa H (2022) A bibliometric analysis and review of nudge research using VOSviewer. Behav Sci (Basel). https:\/\/doi.org\/10.3390\/bs13010019","journal-title":"Behav Sci (Basel)"},{"key":"5714_CR17","doi-asserted-by":"publisher","first-page":"3897","DOI":"10.1007\/s10571-023-01412-x","volume":"43","author":"C Zhang","year":"2023","unstructured":"Zhang C, Zhang M, Cao X, Jiao B, Zhang W, Yu S et al (2023) Navigating the landscape of MANF research: a scientometric journey with CiteSpace analysis. Cell Mol Neurobiol 43:3897\u20133913","journal-title":"Cell Mol Neurobiol"},{"key":"5714_CR18","doi-asserted-by":"publisher","first-page":"1415","DOI":"10.1007\/s11192-017-2351-9","volume":"111","author":"L Bertoli-Barsotti","year":"2017","unstructured":"Bertoli-Barsotti L, Lando T (2017) A theoretical model of the relationship between the h-index and other simple citation indicators. Scientometrics 111:1415\u20131448","journal-title":"Scientometrics"},{"key":"5714_CR19","doi-asserted-by":"publisher","DOI":"10.3389\/fnhum.2022.981571","author":"K Garg","year":"2022","unstructured":"Garg K, Ranjan M, Krishna V, Singh M, Rezai A (2022) A scientometric analysis of the 100 most cited articles on magnetic resonance guided focused ultrasound. Front Hum Neurosci. https:\/\/doi.org\/10.3389\/fnhum.2022.981571","journal-title":"Front Hum Neurosci"},{"key":"5714_CR20","doi-asserted-by":"publisher","DOI":"10.4103\/idoj.idoj_729_21","author":"H Mondal","year":"2022","unstructured":"Mondal H, Mondal S (2022) A brief review on article-, author-, and journal-level scientometric indices. Indian Dermatol Online J. https:\/\/doi.org\/10.4103\/idoj.idoj_729_21","journal-title":"Indian Dermatol Online J"},{"key":"5714_CR21","doi-asserted-by":"publisher","first-page":"1148","DOI":"10.14283\/jpad.2024.79","volume":"11","author":"A Villar","year":"2024","unstructured":"Villar A, Paladini S, Cossatis J (2024) Periodontal disease and Alzheimer\u2019s: insights from a systematic literature network analysis. The Journal of Prevention of Alzheimer\u2019s Disease 11:1148\u20131165","journal-title":"The Journal of Prevention of Alzheimer's Disease"},{"key":"5714_CR22","doi-asserted-by":"publisher","DOI":"10.1097\/MD.0000000000033160","volume":"102","author":"D Feng","year":"2023","unstructured":"Feng D, Huang S, Wang Q, Lang X, Liu Y, Zhang K (2023) Hotspots and development frontiers of postoperative complications of AD: bibliometric analysis - a review. Medicine (Baltimore) 102:e33160","journal-title":"Medicine (Baltimore)"},{"key":"5714_CR23","doi-asserted-by":"publisher","first-page":"1966","DOI":"10.1002\/alz.12362","volume":"17","author":"KB Rajan","year":"2021","unstructured":"Rajan KB, Weuve J, Barnes LL, McAninch EA, Wilson RS, Evans DA (2021) Population estimate of people with clinical Alzheimer\u2019s disease and mild cognitive impairment in the United States (2020\u20132060). Alzheimers Dement 17:1966\u20131975","journal-title":"Alzheimers Dement"},{"key":"5714_CR24","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1152\/physrev.00030.2022","volume":"104","author":"M Perluigi","year":"2024","unstructured":"Perluigi M, Di Domenico F, Butterfield DA (2024) Oxidative damage in neurodegeneration: roles in the pathogenesis and progression of Alzheimer disease. Physiol Rev 104:103\u2013197","journal-title":"Physiol Rev"},{"key":"5714_CR25","doi-asserted-by":"crossref","unstructured":"Iturria-Medina Y, Sotero RC, Toussaint PJ, Mateos-P\u00e9rez JM, Evans AC, Weiner MW et al (2016) Early role of vascular dysregulation on late-onset Alzheimer\u2019s disease based on multifactorial data-driven analysis. Nat Commun 7:11934","DOI":"10.1038\/ncomms11934"},{"key":"5714_CR26","doi-asserted-by":"publisher","first-page":"499","DOI":"10.1038\/nrn2168","volume":"8","author":"FM LaFerla","year":"2007","unstructured":"LaFerla FM, Green KN, Oddo S (2007) Intracellular amyloid-\u03b2 in Alzheimer\u2019s disease. Nat Rev Neurosci 8:499\u2013509","journal-title":"Nat Rev Neurosci"},{"key":"5714_CR27","doi-asserted-by":"publisher","first-page":"6926","DOI":"10.1523\/JNEUROSCI.0800-08.2008","volume":"28","author":"B Boland","year":"2008","unstructured":"Boland B, Kumar A, Lee S, Platt FM, Wegiel J, Yu WH et al (2008) Autophagy induction and autophagosome clearance in neurons: relationship to autophagic pathology in Alzheimer\u2019s disease. J Neurosci 28:6926\u20136937","journal-title":"J Neurosci"},{"key":"5714_CR28","doi-asserted-by":"publisher","first-page":"649","DOI":"10.1016\/j.cell.2017.07.023","volume":"170","author":"TK Ulland","year":"2017","unstructured":"Ulland TK, Song WM, Huang SC, Ulrich JD, Sergushichev A, Beatty WL et al (2017) TREM2 maintains microglial metabolic fitness in Alzheimer\u2019s disease. Cell 170:649\u201363.e13","journal-title":"Cell"},{"key":"5714_CR29","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0009979","volume":"5","author":"P Spilman","year":"2010","unstructured":"Spilman P, Podlutskaya N, Hart MJ, Debnath J, Gorostiza O, Bredesen D et al (2010) Inhibition of mTOR by rapamycin abolishes cognitive deficits and reduces amyloid-beta levels in a mouse model of Alzheimer\u2019s disease. PLoS ONE 5:e9979","journal-title":"PLoS ONE"},{"key":"5714_CR30","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopha.2023.114473","author":"X Wang","year":"2023","unstructured":"Wang X, Jia J (2023) Magnolol improves Alzheimer\u2019s disease-like pathologies and cognitive decline by promoting autophagy through activation of the AMPK\/mTOR\/ULK1 pathway. Biomed Pharmacother. https:\/\/doi.org\/10.1016\/j.biopha.2023.114473","journal-title":"Biomed Pharmacother"},{"key":"5714_CR31","doi-asserted-by":"publisher","DOI":"10.1038\/s41420-023-01324-1","author":"CZ Yang","year":"2023","unstructured":"Yang CZ, Wang SH, Zhang RH, Lin JH, Tian YH, Yang YQ et al (2023) Neuroprotective effect of astragalin via activating PI3K\/Akt-mTOR-mediated autophagy on APP\/PS1 mice. Cell Death Discov 9:15. https:\/\/doi.org\/10.1038\/s41420-023-01324-1","journal-title":"Cell Death Discov"},{"key":"5714_CR32","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1515\/revneuro-2019-0058","volume":"31","author":"DM Cuestas Torres","year":"2020","unstructured":"Cuestas Torres DM, Cardenas FP (2020) Synaptic plasticity in Alzheimer\u2019s disease and healthy aging. Rev Neurosci 31:245\u2013268","journal-title":"Rev Neurosci"},{"key":"5714_CR33","doi-asserted-by":"crossref","unstructured":"Feany MB, Ma T, Hoeffer CA, Capetillo-Zarate E, Yu F, Wong H et al (2010) Dysregulation of the mTOR pathway mediates impairment of synaptic plasticity in a mouse model of Alzheimer's disease. PLoS ONE 5:e12845","DOI":"10.1371\/journal.pone.0012845"},{"key":"5714_CR34","doi-asserted-by":"publisher","first-page":"647","DOI":"10.1016\/j.exger.2013.02.025","volume":"48","author":"NC O\u2019","year":"2013","unstructured":"O\u2019 NC (2013) PI3-kinase\/Akt\/mTOR signaling: impaired on\/off switches in aging, cognitive decline and Alzheimer\u2019s disease. Exp Gerontol 48:647\u2013653","journal-title":"Exp Gerontol"},{"key":"5714_CR35","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1002\/cm.21782","volume":"81","author":"GS Bloom","year":"2023","unstructured":"Bloom GS, Norambuena A (2023) Dysregulation of mTOR by tau in Alzheimer\u2019s disease. Cytoskeleton 81:30\u201334","journal-title":"Cytoskeleton"},{"key":"5714_CR36","doi-asserted-by":"publisher","first-page":"1669","DOI":"10.1007\/s10787-021-00889-6","volume":"29","author":"R Dhapola","year":"2021","unstructured":"Dhapola R, Hota SS, Sarma P, Bhattacharyya A, Medhi B, Reddy DH (2021) Recent advances in molecular pathways and therapeutic implications targeting neuroinflammation for Alzheimer\u2019s disease. Inflammopharmacology 29:1669\u20131681","journal-title":"Inflammopharmacology"},{"key":"5714_CR37","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1080\/15548627.2019.1596488","volume":"16","author":"R Luo","year":"2019","unstructured":"Luo R, Su L-Y, Li G, Yang J, Liu Q, Yang L-X et al (2019) Activation of PPARA-mediated autophagy reduces Alzheimer disease-like pathology and cognitive decline in a murine model. Autophagy 16:52\u201369","journal-title":"Autophagy"},{"key":"5714_CR38","doi-asserted-by":"publisher","DOI":"10.3389\/fnagi.2018.00225","volume":"10","author":"J Lee","year":"2018","unstructured":"Lee J, Yanckello LM, Ma D, Hoffman JD, Parikh I, Thalman S et al (2018) Neuroimaging biomarkers of mTOR inhibition on vascular and metabolic functions in aging brain and Alzheimer\u2019s disease. Front Aging Neurosci 10:225","journal-title":"Front Aging Neurosci"},{"key":"5714_CR39","doi-asserted-by":"publisher","first-page":"1745","DOI":"10.1177\/0271678X241261942","volume":"44","author":"BG Sanganahalli","year":"2024","unstructured":"Sanganahalli BG, Mihailovic JM, Vekaria HJ, Coman D, Yackzan AT, Flemister A et al (2024) mTOR inhibition enhances synaptic and mitochondrial function in Alzheimer\u2019s disease in an APOE genotype-dependent manner. J Cereb Blood Flow Metab 44:1745\u20131758","journal-title":"J Cereb Blood Flow Metab"},{"key":"5714_CR40","doi-asserted-by":"publisher","DOI":"10.1111\/cns.14463","volume":"30","author":"S Davoody","year":"2024","unstructured":"Davoody S, Asgari Taei A, Khodabakhsh P, Dargahi L (2024) mTOR signaling and Alzheimer\u2019s disease: what we know and where we are? CNS Neurosci Ther 30:e14463","journal-title":"CNS Neurosci Ther"},{"key":"5714_CR41","doi-asserted-by":"publisher","DOI":"10.1016\/j.neuint.2022.105311","volume":"155","author":"D Rapaka","year":"2022","unstructured":"Rapaka D, Bitra VR, Challa SR, Adiukwu PC (2022) mTOR signaling as a molecular target for the alleviation of Alzheimer\u2019s disease pathogenesis. Neurochem Int 155:105311","journal-title":"Neurochem Int"},{"key":"5714_CR42","doi-asserted-by":"publisher","first-page":"3103","DOI":"10.1007\/s11064-021-03418-7","volume":"46","author":"VK Sharma","year":"2021","unstructured":"Sharma VK, Singh TG, Singh S, Garg N, Dhiman S (2021) Apoptotic pathways and Alzheimer\u2019s disease: probing therapeutic potential. Neurochem Res 46:3103\u20133122","journal-title":"Neurochem Res"},{"key":"5714_CR43","doi-asserted-by":"publisher","first-page":"2769","DOI":"10.1007\/s11357-023-00935-x","volume":"45","author":"AR Konopka","year":"2023","unstructured":"Konopka AR, Lamming DW (2023) Blazing a trail for the clinical use of rapamycin as a geroprotecTOR. Geroscience 45:2769\u20132783","journal-title":"Geroscience"},{"key":"5714_CR44","doi-asserted-by":"publisher","first-page":"1249","DOI":"10.1038\/s43587-025-00876-4","volume":"5","author":"L Gkioni","year":"2025","unstructured":"Gkioni L, Nespital T, Baghdadi M, Monz\u00f3 C, Bali J, Nassr T et al (2025) The geroprotectors trametinib and rapamycin combine additively to extend mouse healthspan and lifespan. Nat Aging 5:1249\u20131265","journal-title":"Nat Aging"},{"key":"5714_CR45","doi-asserted-by":"crossref","unstructured":"Vicente M, Addo-Osafo K, Vossel K (2024) Latest advances in mechanisms of epileptic activity in Alzheimer\u2019s disease and dementia with Lewy Bodies. Front Neurol 15:1277613","DOI":"10.3389\/fneur.2024.1277613"},{"key":"5714_CR46","doi-asserted-by":"publisher","first-page":"493","DOI":"10.1016\/j.cmet.2019.06.005","volume":"30","author":"SH Baik","year":"2019","unstructured":"Baik SH, Kang S, Lee W, Choi H, Chung S, Kim J-I et al (2019) A breakdown in metabolic reprogramming causes microglia dysfunction in Alzheimer\u2019s disease. Cell Metab 30:493-507.e6","journal-title":"Cell Metab"},{"key":"5714_CR47","doi-asserted-by":"publisher","first-page":"706","DOI":"10.1016\/j.biopsych.2023.02.008","volume":"94","author":"L Yang","year":"2023","unstructured":"Yang L, Liu W, Shi L, Wu J, Zhang W, Chuang Y-A et al (2023) NMDA receptor\u2013arc signaling is required for memory updating and is disrupted in Alzheimer\u2019s disease. Biol Psychiatry 94:706\u2013720","journal-title":"Biol Psychiatry"},{"key":"5714_CR48","doi-asserted-by":"publisher","first-page":"3833","DOI":"10.1080\/15548627.2021.1886720","volume":"17","author":"X Zheng","year":"2021","unstructured":"Zheng X, Lin W, Jiang Y, Lu K, Wei W, Huo Q et al (2021) Electroacupuncture ameliorates beta-amyloid pathology and cognitive impairment in Alzheimer disease via a novel mechanism involving activation of TFEB (transcription factor EB). Autophagy 17:3833\u20133847","journal-title":"Autophagy"},{"key":"5714_CR49","doi-asserted-by":"publisher","DOI":"10.3389\/fnagi.2017.00173","author":"MA Shafei","year":"2017","unstructured":"Shafei MA, Harris M, Conway ME (2017) Divergent metabolic regulation of autophagy and mTORC1\u2014early events in Alzheimer\u2019s disease? Front Aging Neurosci. https:\/\/doi.org\/10.3389\/fnagi.2017.00173","journal-title":"Front Aging Neurosci"},{"key":"5714_CR50","doi-asserted-by":"publisher","first-page":"511","DOI":"10.1016\/j.apsb.2021.06.014","volume":"12","author":"SN Austad","year":"2022","unstructured":"Austad SN, Ballinger S, Buford TW, Carter CS, Smith DL Jr., Darley-Usmar V et al (2022) Targeting whole body metabolism and mitochondrial bioenergetics in the drug development for Alzheimer\u2019s disease. Acta Pharm Sin B 12:511\u2013531","journal-title":"Acta Pharm Sin B"},{"key":"5714_CR51","doi-asserted-by":"publisher","DOI":"10.1016\/j.arr.2022.101619","volume":"77","author":"R Bai","year":"2022","unstructured":"Bai R, Guo J, Ye XY, Xie Y, Xie T (2022) Oxidative stress: the core pathogenesis and mechanism of Alzheimer\u2019s disease. Ageing Res Rev 77:101619","journal-title":"Ageing Res Rev"},{"key":"5714_CR52","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejphar.2022.175301","volume":"934","author":"MP Morawe","year":"2022","unstructured":"Morawe MP, Liao F, Amberg W, van Bergeijk J, Chang R, Gulino M et al (2022) Pharmacological mTOR-inhibition facilitates clearance of AD-related tau aggregates in the mouse brain. Eur J Pharmacol 934:175301","journal-title":"Eur J Pharmacol"},{"key":"5714_CR53","doi-asserted-by":"publisher","first-page":"802","DOI":"10.1002\/jrsm.1729","volume":"15","author":"M Gusenbauer","year":"2024","unstructured":"Gusenbauer M (2024) Beyond Google scholar, Scopus, and Web of Science: an evaluation of the backward and forward citation coverage of 59 databases\u2019 citation indices. Res Synth Methods 15:802\u2013817","journal-title":"Res Synth Methods"}],"container-title":["Molecular Neurobiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12035-026-05714-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12035-026-05714-1","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12035-026-05714-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,5]],"date-time":"2026-02-05T17:34:02Z","timestamp":1770312842000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12035-026-05714-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1]]},"references-count":53,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026,1]]}},"alternative-id":["5714"],"URL":"https:\/\/doi.org\/10.1007\/s12035-026-05714-1","relation":{},"ISSN":["0893-7648","1559-1182"],"issn-type":[{"value":"0893-7648","type":"print"},{"value":"1559-1182","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1]]},"assertion":[{"value":"29 May 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 January 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 February 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics Approval"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to Participate"}},{"value":"Not applicable.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for Publication"}},{"value":"The authors declare no competing interests.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"421"}}